BHI News Section Archives - Page 45 of 1201

News

May 23, 2024

Nona Biosciences Announces Global License and Option Agreement with AstraZeneca for Monoclonal Antibody to be Developed into Novel Tumor Targeted Therapies

Nona Biosciences, a global biotechnology company providing a total solution from “Idea to IND” (I to ITM), ranging from target…

Andy

Love0

News

May 22, 2024

Frederick’s Theradaptive Secures $1M in Funding from Maryland Stem Cell Research Fund for Human Clinical Trials

FREDERICK, Md., May 22, 2024 /PRNewswire/ -- Theradaptive, Inc., a regenerative medicine company developing targeted therapeutics, announced today it has been awarded…

Andy

Love0

News

May 22, 2024

PQE Group US Earns Great Place to Work Certification™

Rockville, MD, May 22, 2024. PQE Group is proud to announce that, for the third consecutive year, its US subsidiary…

Andy

Love0

News

May 22, 2024

MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development

Legend Biotech obtains license to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support its non-viral engineered pipeline portfolio…

Andy

Love0

News

May 22, 2024

Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Descartes-08 for the Treatment of Myasthenia Gravis

GAITHERSBURG, Md., May 22, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering…

Andy

Love0

News

May 21, 2024

Welldoc Certified as a Great Place to Work® for Third Year in a Row

COLUMBIA, Md., May 21, 2024 — Welldoc®, a leading digital health company specializing in AI-driven cardiometabolic health, announced today that it was…

Andy

Love0

News

May 20, 2024

Save the Dates: 2024 BioHealth Capital Region Week Registration Coming Soon

Looking forward to the Autumn of 2024, the BioHealth Capital Region is gearing up for three major events, September 17th,…

Andy

Love0

News

May 20, 2024

Gaithersburg’s Amplexd Therapeutics, Innovating to Revolutionize the Future of Non-Invasive HPV-induced Cervical Intraepithelial Neoplasia (CIN) Treatments for the Prevention of Cervical Cancer: Developed by Women for Women

GAITHERSBURG, MD, May 20, 2024 (GLOBE NEWSWIRE) -- Amplexd Therapeutics, Inc. (“Amplexd” or the “Company”), a clinical stage patient-scientist-led biotech…

Andy

Love0

News

May 20, 2024

Baltimore Fishbowl: MCB Real Estate announces plans for a mixed-use development in Montgomery County that will have a focus on the life sciences and biohealth

MCB Real Estate, the developer of Harborplace in Baltimore, announced on Thursday that it will lead the development of VIVA…

Andy

Love0

News

May 16, 2024

Vanda Pharmaceuticals Reports Positive Results from a Second Phase III Study of Tradipitant in Motion Sickness

WASHINGTON, May 15, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the results from its second Phase III study of…

Andy

Love0

BHI News Section

Nona Biosciences Announces Global License and Option Agreement with AstraZeneca for Monoclonal Antibody to be Developed into Novel Tumor Targeted Therapies

Frederick’s Theradaptive Secures $1M in Funding from Maryland Stem Cell Research Fund for Human Clinical Trials

PQE Group US Earns Great Place to Work Certification™

MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development

Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Descartes-08 for the Treatment of Myasthenia Gravis

Welldoc Certified as a Great Place to Work® for Third Year in a Row

Save the Dates: 2024 BioHealth Capital Region Week Registration Coming Soon

Gaithersburg’s Amplexd Therapeutics, Innovating to Revolutionize the Future of Non-Invasive HPV-induced Cervical Intraepithelial Neoplasia (CIN) Treatments for the Prevention of Cervical Cancer: Developed by Women for Women

Baltimore Fishbowl: MCB Real Estate announces plans for a mixed-use development in Montgomery County that will have a focus on the life sciences and biohealth

Vanda Pharmaceuticals Reports Positive Results from a Second Phase III Study of Tradipitant in Motion Sickness

About BioHealth Innovation

Contact

Connect

BHI News Section

About BioHealth Innovation

Contact

Connect

Search